Stock listing
Frankfurt:PHG Pharming Group NV Aktie
German listing (Frankfurt) of Pharming Group NV · home listing Euronext:PHARM
Follow Pharming Group NV into a list and get an email when it puts out news.
Share price · FWB:PHG
€10.90 EUR -0.30 (-2.7%)
Close on Nov 17, 2026
- Day range
- €10.90 – €11.10 EURNov 17, 2026
- Market cap
- €771.5M EURAt the close on Nov 17, 2026 · price × 70.78M shares outstanding
- 52-week range
- €7.68 – €17.56 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €100 EURMedian day 0 shares · 59 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:PHARM · Home | €1.117 EUR | -0.004 (-0.4%) | 4,519,835 | €1.12 | €1.134 | €1.113 | €1.122 | Close on Nov 18, 2026 |
| NASDAQ:PHAR | $12.06 USD | -0.53 (-4.2%) | 8,319 | $12.26 | $12.35 | $12.06 | $12.59 | Close on Nov 17, 2026 |
| OTC:PHGUF | $1.26 USD | 0.00 (0.0%) | — | $1.26 | $1.26 | $1.26 | $1.26 | Close on Nov 6, 2026 |
| Frankfurt:PHG | €10.90 EUR | -0.30 (-2.7%) | — | €10.90 | €11.10 | €10.90 | €11.20 | Close on Nov 17, 2026 |
| Stuttgart:PHGN | €1.068 EUR | -0.038 (-3.4%) | 2,437 | €1.103 | €1.132 | €1.068 | €1.106 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:PHG · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €10.54 | -0.143 | -1.3% | €10.46 | €10.56 | €10.40 | 0 | |
| €10.68 | -0.222 | -2.0% | €10.60 | €10.76 | €10.57 | 0 | |
| €10.90 | -0.106 | -1.0% | €10.98 | €11.02 | €10.90 | 550 | |
| €11.01 | +0.05 | +0.5% | €10.89 | €11.37 | €10.87 | 0 | |
| €10.96 | +0.315 | +3.0% | €10.47 | €11.01 | €10.42 | 0 | |
| €10.64 | -0.106 | -1.0% | €10.33 | €10.69 | €10.24 | 0 | |
| €10.75 | +0.131 | +1.2% | €10.33 | €10.86 | €10.31 | 0 | |
| €10.62 | +0.12 | +1.1% | €10.19 | €10.65 | €10.18 | 0 | |
| €10.50 | +0.033 | +0.3% | €10.20 | €10.50 | €10.16 | 0 | |
| €10.46 | +0.846 | +8.8% | €9.586 | €10.60 | €9.405 | 0 | |
| €9.617 | +1.468 | +18.0% | €9.069 | €9.632 | €9.055 | 0 | |
| €8.149 | +0.021 | +0.3% | €8.149 | €8.149 | €8.149 | 0 | |
| €8.128 | +0.071 | +0.9% | €8.171 | €8.172 | €8.099 | 0 | |
| €8.057 | +0.078 | +1.0% | €7.739 | €8.174 | €7.684 | 0 | |
| €7.979 | -0.171 | -2.1% | €7.974 | €7.989 | €7.971 | 0 | |
| €8.15 | -0.013 | -0.2% | €8.202 | €8.328 | €8.15 | 0 | |
| €8.163 | -0.098 | -1.2% | €8.213 | €8.244 | €8.081 | 0 | |
| €8.261 | -0.015 | -0.2% | €8.042 | €8.374 | €8.039 | 0 | |
| €8.276 | -0.193 | -2.3% | €8.228 | €8.426 | €8.228 | 0 | |
| €8.469 | +0.065 | +0.8% | €8.282 | €8.518 | €8.25 | 0 | |
| €8.404 | +0.131 | +1.6% | €8.124 | €8.439 | €8.122 | 0 | |
| €8.273 | -0.003 | 0.0% | €8.241 | €8.302 | €8.216 | 0 | |
| €8.276 | -0.212 | -2.5% | €8.213 | €8.284 | €8.152 | 0 | |
| €8.488 | +0.091 | +1.1% | €8.284 | €8.611 | €8.269 | 0 | |
| €8.397 | +0.014 | +0.2% | €8.263 | €8.483 | €8.249 | 0 | |
| €8.383 | +0.17 | +2.1% | €8.405 | €8.415 | €8.383 | 0 | |
| €8.213 | -0.446 | -5.2% | €8.338 | €8.388 | €8.104 | 0 | |
| €8.659 | +0.054 | +0.6% | €8.382 | €8.663 | €8.327 | 0 | |
| €8.605 | -0.274 | -3.1% | €8.838 | €8.867 | €8.592 | 0 | |
| €8.879 | +0.058 | +0.7% | €8.834 | €8.89 | €8.808 | 0 | |
| €8.821 | -0.097 | -1.1% | €8.768 | €8.956 | €8.744 | 0 | |
| €8.918 | -0.226 | -2.5% | €8.921 | €8.966 | €8.853 | 0 | |
| €9.144 | -0.016 | -0.2% | €9.272 | €9.275 | €9.135 | 0 | |
| €9.16 | +0.343 | +3.9% | €8.978 | €9.198 | €8.953 | 0 | |
| €8.817 | -0.182 | -2.0% | €8.791 | €8.82 | €8.72 | 0 | |
| €8.999 | +0.119 | +1.3% | €8.961 | €9.061 | €8.935 | 0 | |
| €8.88 | -0.038 | -0.4% | €8.79 | €8.994 | €8.694 | 0 | |
| €8.918 | +0.054 | +0.6% | €8.773 | €8.926 | €8.737 | 0 | |
| €8.864 | -0.09 | -1.0% | €8.851 | €8.864 | €8.831 | 0 | |
| €8.954 | +0.009 | +0.1% | €9.23 | €9.24 | €8.939 | 0 | |
| €8.945 | -0.12 | -1.3% | €8.899 | €8.955 | €8.873 | 0 | |
| €9.065 | -0.175 | -1.9% | €9.014 | €9.144 | €8.936 | 0 | |
| €9.24 | +0.073 | +0.8% | €9.31 | €9.31 | €9.239 | 0 | |
| €9.167 | -0.19 | -2.0% | €9.29 | €9.384 | €9.167 | 0 | |
| €9.357 | +0.047 | +0.5% | €9.281 | €9.42 | €9.221 | 0 | |
| €9.31 | -0.055 | -0.6% | €9.319 | €9.32 | €9.297 | 0 | |
| €9.365 | -0.066 | -0.7% | €9.187 | €9.492 | €9.177 | 0 | |
| €9.431 | +0.091 | +1.0% | €9.189 | €9.446 | €9.185 | 0 | |
| €9.34 | -0.14 | -1.5% | €9.342 | €9.363 | €9.303 | 0 | |
| €9.48 | -0.106 | -1.1% | €9.505 | €9.511 | €9.469 | 0 | |
| €9.586 | -0.154 | -1.6% | €9.668 | €9.871 | €9.586 | 0 | |
| €9.74 | -0.046 | -0.5% | €9.79 | €9.858 | €9.696 | 0 | |
| €9.786 | +0.189 | +2.0% | €9.582 | €9.798 | €9.524 | 0 | |
| €9.597 | +0.065 | +0.7% | €9.443 | €9.613 | €9.443 | 0 | |
| €9.532 | -0.037 | -0.4% | €9.625 | €9.631 | €9.452 | 0 | |
| €9.569 | -0.153 | -1.6% | €9.523 | €9.581 | €9.455 | 0 | |
| €9.722 | +0.01 | +0.1% | €9.736 | €9.852 | €9.722 | 0 | |
| €9.712 | +0.039 | +0.4% | €9.762 | €9.774 | €9.565 | 0 | |
| €9.673 | +0.041 | +0.4% | €9.728 | €9.758 | €9.641 | 0 | |
| €9.632 | -0.077 | -0.8% | €9.604 | €9.683 | €9.562 | 0 |
- Ticker
- Frankfurt:PHG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 6, 2026
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Latest earnings call · Jul 30, 2026
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 40 slides
Calls
Replays
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q1 2026 Earnings Call
Thu, May 07, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 8:30 AM ET
Watch Transcript
Latest news
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Nov 6, 2026
Closed €10.54 (-1.3%) on Nov 6, 2026
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
Oct 27, 2026
Closed €10.50 (+0.3%) on Oct 27, 2026
Pharming Group announces third quarter 2026 revenues above market expectations
Oct 22, 2026
Closed €8.15 (+0.3%) on Oct 22, 2026
Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
Oct 14, 2026
Closed €8.26 (-0.2%) on Oct 14, 2026
Pharming announces CEO transition
Sep 29, 2026
Closed €8.61 (-3.1%) on Sep 29, 2026
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
Sep 25, 2026
Closed €8.88 (+0.7%) on Sep 28, 2026
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
Sep 22, 2026
Closed €9.16 (+3.9%) on Sep 22, 2026
FDA approves Pharming's Joenja(R) as first treatment for children with APDS in the U.S.
Sep 14, 2026
Closed €8.86 (-1.0%) on Sep 15, 2026
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
Sep 11, 2026
Closed €8.95 (+0.1%) on Sep 14, 2026
Pharming Group to participate in September investor conferences
Sep 9, 2026
Closed €9.24 (+0.8%) on Sep 9, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 40 slides · November 2026
Q3 2026 Earnings Presentation
Earnings · 32 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 41 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026
Pharming Group NV on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 55 in all · newest Nov 6, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Jul 30, 2026
- Decks
- 85 decks · latest November 2026
Where Pharming Group NV is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:PHARM · Home listing | Euronext | Netherlands | EUR |
| NASDAQ:PHAR | NASDAQ | United States | USD |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| LSIN:0QCO | LSIN | United Kingdom | EUR |
| gettex:PHGN | gettex | Germany | EUR |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| Tradegate:PHGN | Tradegate | Germany | EUR |
| Xetra:PHGN | Xetra | Germany | EUR |
| LS Exchange:A1H65A | LS Exchange | Germany | EUR |
| OTC:PHGUF | OTC | United States | USD |
| BOATS:PHAR | BOATS | United States | USD |
| Turquoise:PHARMA | Turquoise | United Kingdom | EUR |
| gettex:PHG | gettex | Germany | EUR |
| Lang & Schwarz:A1H65A | Lang & Schwarz | Germany | EUR |
| Frankfurt:PHGN | Frankfurt | Germany | EUR |
| Hamburg:PHGN | Hamburg | Germany | EUR |
| Stuttgart:PHG | Stuttgart | Germany | EUR |
| BX Swiss:PHGN | BX Swiss | Switzerland | CHF |
| Dusseldorf:PHGN | Dusseldorf | Germany | EUR |
| Frankfurt:PHG · This page | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QLQY | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2QLQY | LS Exchange | Germany | EUR |
| Munich:PHGN | Munich | Germany | EUR |
| Dusseldorf:PHG | Dusseldorf | Germany | EUR |
| Munich:PHG | Munich | Germany | EUR |
| Stuttgart:PHGN | Stuttgart | Germany | EUR |
| Hanover:PHGN | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Pharming Group NV.